 |
|
|
| Poster session: Myeloma - Thalidomide and novel drugs |
| Date: | Saturday, 8 June 2002 |
| Time: | 17:15-18:45 |
| Room: | |
| 17:15-18:45 |
1131 |
|
|
Durability of response with thalidomide therapy for relapsed myeloma
B. Myers, G. Dolan (Nottingham, United Kingdom)
| 17:15-18:45 |
1132 |
|
|
INTERACTIONS BETWEEN MYELOMA AND ENDOTHELIAL CELLS AND THE EFFECTS OF THALIDOMIDE AND ITS ANALOGUES
G.S. Molostvov, A.G. Morris, P. Rose, S. Basu (Coventry, United Kingdom)
| 17:15-18:45 |
1133 |
|
|
Thalidomide plus melphalan as salvage therapy of advanced multiple myeloma
A. Mele, M. Offidani, M. Marconi, M. Catarini, M. Brunori, M. Candela, D. Capelli, A. Olivieri, S. Rupoli, L. Corvatta, L. Malerba, P. Leoni (Ancona, Italy)
| 17:15-18:45 |
1134 |
|
|
ARSENIC TRIOXIDE (ATO) IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA (MM): A PHASE II CLINICAL STUDY
M.A. Hussein, C. Paradise, R. Carozza, M. Saleh, R.M. Rifkin, F. Ravandi, J. Mason (Cleveland, United States of America)
| 17:15-18:45 |
1135 |
|
|
Thalidomide (THAL) Treatment in Relapsed/Refractory Multiple Myeloma(MM). A Retrospective Multicenter Study
A. Andriani, A. Ferrari, M. Montanaro, G. Niscola, L. Scaramucci, U. Recine, A. Chierichini, M. Bibas (Roma, Italy)
| 17:15-18:45 |
1136 |
|
|
BONE MARROW ANGIOGENESIS AND SERUM ANGIOGENIC CYTOKINES IN MULTIPLE MYELOMA
A. Chaidos, M. Bai, St. Tsiara, I. Schina, P. Manousou, E. Tzouvara, P. Kanavaros, K.L. Bourantas (Ioannina, Greece)
| 17:15-18:45 |
1137 |
|
|
PROTEASOME ACTIVITY IN MULTIPLE MYELOMA
L. Magill, T.C.M. Morris, D. Alexander, M. Martin, J. Lynas, B. Walker, A.E. Irvine (Belfast, Northern Ireland)
| 17:15-18:45 |
1138 |
|
|
BONE MARROW MORPHOLOGICAL CHANGES IN REFRACTORY MYELOMA PATIENTS DURING TREATMENT WITH THALIDOMIDE
A.L. Lorenzi, A.C. Corso, P.Z. Zappasodi, E.O. Orlandi, C.A. Astori, L.V. Vanelli, L.A. Arcaini, S.M. Mangiacavalli, C.R. Rusconi, M.L. Lazzarino (Pavia, Italy)
| 17:15-18:45 |
1139 |
|
|
EFFECTS OF PROTEASOME INHIBITORS IN MYELOMA CELL LINES AND ISOLATED HUMAN MYELOMA CELLS
I. Zavrski, K. Niemöller, C. Jakob, U. Heider, J. Eucker, K. Possinger, O. Sezer (Berlin, Germany)
| 17:15-18:45 |
1140 |
|
|
THALIDOMIDE TREATMENT IN MULTIPLE MYELOMA
K.S. Strasser, Th. Dorda, H. Ludwig (Vienna, Austria)
| 17:15-18:45 |
1141 |
|
|
PHARMACOKINETICS OF TROFOSFAMIDE AND ITS METABOLITES IN MYELOMA PATIENTS - FIRST DETERMINATION OF THE ACTIVE 4-OH-DERIVATIVE OF TROFOSFAMIDE IN HUMANS
R. Preiss, F. Baumann, D. Stefanovic, J. Möckel, D. Niederwieser (Leipzig, Germany)
|